Antifungal use via outpatient parenteral antimicrobial therapy
Sign Up to like & getrecommendations! Published in 2022 at "Mycoses"
DOI: 10.1111/myc.13513
Abstract: Antifungal administration via outpatient parenteral antimicrobial therapy (OPAT) is infrequent. As patients with invasive fungal infections (IFIs) receiving OPAT are at high risk of readmissions, careful, risk‐based patient selection and monitoring is important. read more here.
Keywords: antifungal use; parenteral antimicrobial; antimicrobial therapy; outpatient parenteral ... See more keywords
Variability in antifungal utilization among neonatal, pediatric, and adult inpatients in academic medical centers throughout the United States of America
Sign Up to like & getrecommendations! Published in 2018 at "BMC Infectious Diseases"
DOI: 10.1186/s12879-018-3410-4
Abstract: BackgroundIdentification of factors associated with antifungal utilization in neonatal, pediatric, and adult patient groups is needed to guide antifungal stewardship initiatives in academic medical centers.MethodsFor this hospital-level analysis, we analyzed antifungal use in hospitals across… read more here.
Keywords: antifungal use; use; neonatal pediatric; pediatric adult ... See more keywords
Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria responsible for activities that enhance colonic defense
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cellular and Infection Microbiology"
DOI: 10.3389/fcimb.2022.924707
Abstract: Due to decreased immunity, both antibiotics and antifungals are regularly used in pediatric hematologic-cancer patients as a means to prevent severe infections and febrile neutropenia. The general effect of antibiotics on the human gut microbiome… read more here.
Keywords: oncology; leukemia lymphoma; antifungal use; use ... See more keywords